AMAG Pharmaceuticals Acciones en circulación

¿Qué es el Acciones en circulación de AMAG Pharmaceuticals?

El Acciones en circulación de AMAG Pharmaceuticals, Inc. es 34.725M

¿Cuál es la definición de Acciones en circulación?



Las acciones en circulación son todas las acciones de una corporación o de un activo financiero que han sido autorizadas, emitidas y compradas por los inversionistas y son retenidas por ellos.

Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.

Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.

Acciones en circulación de compañías en Sector Health Care en NASDAQ en comparadas con AMAG Pharmaceuticals

¿Qué hace AMAG Pharmaceuticals?

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

Empresas con acciones en circulación similar a AMAG Pharmaceuticals